{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:28:50Z","timestamp":1781162930225,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10067-026-08038-6","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:34:14Z","timestamp":1774247654000},"page":"2483-2496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0017-1842","authenticated-orcid":false,"given":"Jie Ying","family":"Tee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-9418","authenticated-orcid":false,"given":"Azeem","family":"Thahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2172-2849","authenticated-orcid":false,"given":"Matija","family":"Krkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"10182","key":"8038_CR1","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393(10182):1745\u20131759. https:\/\/doi.org\/10.1016\/S0140-6736(19)30417-9","journal-title":"Lancet"},{"issue":"1","key":"8038_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/jehp.jehp_1621_24","volume":"15","author":"M Shamsaei","year":"2026","unstructured":"Shamsaei M, Raeissi P, Ebrahimi-Takamjani I, Gorji HA, Hashemi M (2026Jan 1) Osteoarthritis as a silent threat to the health of Iranians: A systematic review. Journal of Education and Health Promotion. 15(1):30","journal-title":"Journal of Education and Health Promotion."},{"issue":"2","key":"8038_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J et al (2020) 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 72(2):220\u2013233. https:\/\/doi.org\/10.1002\/art.41142","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"8038_CR4","doi-asserted-by":"publisher","first-page":"E721","DOI":"10.5435\/JAAOS-D-21-01233","volume":"30","author":"RH Brophy","year":"2022","unstructured":"Brophy RH, Fillingham YA (2022) AAOS clinical practice guideline summary: management of osteoarthritis of the knee (nonarthroplasty), third edition. J Am Acad Orthop Surg 30(9):E721\u2013E729. https:\/\/doi.org\/10.5435\/JAAOS-D-21-01233","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"8038_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225041","volume":"83","author":"T Moseng","year":"2024","unstructured":"Moseng T, Vliet Vlieland TPM, Battista S, Beckw\u00e9e D, Boyadzhieva V, Conaghan PG et al (2024) EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis 83(1):730. https:\/\/doi.org\/10.1136\/ard-2023-225041","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8038_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.N2321","volume":"375","author":"BR Da Costa","year":"2021","unstructured":"Da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS et al (2021) Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ 375(12):2321. https:\/\/doi.org\/10.1136\/BMJ.N2321","journal-title":"BMJ"},{"key":"8038_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1539328","volume":"16","author":"H Han","year":"2025","unstructured":"Han H, Ro DH, Han HS, Won S (2025) Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study. Front Pharmacol 16:1539328. https:\/\/doi.org\/10.3389\/fphar.2025.1539328","journal-title":"Front Pharmacol"},{"issue":"2","key":"8038_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.joca.2025.12.013","volume":"34","author":"F Scerif","year":"2025","unstructured":"Scerif F, Eldridge SE (2025) Osteoarthritis year in review 2025: biology. Osteoarthritis Cartilage 34(2):213\u2013220. https:\/\/doi.org\/10.1016\/j.joca.2025.12.013","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"8038_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jot.2025.08.009","volume":"55","author":"T Jiang","year":"2025","unstructured":"Jiang T, Su S, Tian R, Jiao Y, Zheng S, Liu T et al (2025) Immunoregulatory orchestrations in osteoarthritis and mesenchymal stromal cells for therapy. J Orthop Translat 55(1):38. https:\/\/doi.org\/10.1016\/j.jot.2025.08.009","journal-title":"J Orthop Translat"},{"issue":"11","key":"8038_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111438","volume":"17","author":"G C\u00e1sedas","year":"2024","unstructured":"C\u00e1sedas G, Yarza-Sancho M, L\u00f3pez V (2024) Cannabidiol (CBD): a systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals 17(11):1438. https:\/\/doi.org\/10.3390\/ph17111438","journal-title":"Pharmaceuticals"},{"key":"8038_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.793750","volume":"12","author":"Y Xin","year":"2022","unstructured":"Xin Y, Tang A, Pan S, Zhang J (2022) Components of the endocannabinoid system and effects of cannabinoids against bone diseases: a mini-review. Front Pharmacol 12:35126132. https:\/\/doi.org\/10.3389\/fphar.2021.793750","journal-title":"Front Pharmacol"},{"key":"8038_CR12","doi-asserted-by":"publisher","unstructured":"Chou R, Ahmed AY, Dana T, Morasco BJ, Bougatsos C, Fu R, et al. (2025) Living systematic review on cannabis and other plant-based treatments for chronic pain: 2025 update .\u00a0https:\/\/doi.org\/10.23970\/AHRQEPCCER250UPDATE2025 PubMed PMID: 40956916.","DOI":"10.23970\/AHRQEPCCER250UPDATE2025"},{"issue":"7","key":"8038_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/03007995.2024.2363945","volume":"40","author":"C Dubois","year":"2024","unstructured":"Dubois C, Danielson EC, Beestrum M, Eurich DT (2024) Medical cannabis and its efficacy\/effectiveness on the management of osteoarthritis pain and function. Curr Med Res Opin 40(7):1195\u20131202. https:\/\/doi.org\/10.1080\/03007995.2024.2363945","journal-title":"Curr Med Res Opin"},{"key":"8038_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint17090141","author":"A Sic","year":"2025","unstructured":"Sic A, George C, Gonzalez DF, Tseriotis VS, Knezevic NN (2025) Cannabinoids in chronic pain: clinical outcomes, adverse effects and legal challenges. Neurol Int. https:\/\/doi.org\/10.3390\/neurolint17090141","journal-title":"Neurol Int"},{"issue":"2","key":"8038_CR15","doi-asserted-by":"publisher","DOI":"10.1089\/CAN.2021.0156","volume":"9","author":"AD Bell","year":"2024","unstructured":"Bell AD, MacCallum C, Margolese S, Walsh Z, Wright P, Daeninck PJ et al (2024) Clinical practice guidelines for cannabis and cannabinoid-based medicines in the management of chronic pain and co-occurring conditions. Cannabis Cannabinoid Res 9(2):669. https:\/\/doi.org\/10.1089\/CAN.2021.0156","journal-title":"Cannabis Cannabinoid Res"},{"key":"8038_CR16","doi-asserted-by":"publisher","unstructured":"Lefebvre \u00c8, Tawil N, Yahia L. Transdermal delivery of cannabidiol for the management of acute inflammatory pain: a comprehensive review of the literature. International Journal of Molecular Sciences 2024, Vol 25, Page 5858. 2024 May 28;25(11):5858. https:\/\/doi.org\/10.3390\/IJMS25115858 PubMed PMID: 38892047.","DOI":"10.3390\/IJMS25115858"},{"issue":"6","key":"8038_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/ACR.24176","volume":"75","author":"MA Fitzcharles","year":"2023","unstructured":"Fitzcharles MA, Clauw DJ, H\u00e4user W (2023Jun 1) Cautious hope for cannabidiol (CBD) in rheumatology care. Arthritis Care Res (Hoboken) 75(6):1371\u20131375. https:\/\/doi.org\/10.1002\/ACR.24176","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"8038_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14712\/23362936.2023.17","volume":"124","author":"M Sklen\u00e1rov\u00e1","year":"2023","unstructured":"Sklen\u00e1rov\u00e1 M, \u0160\u00edma M, Slana\u0159 O (2023) Effects of cannabidiol in inflammation: a review of pre-clinical and clinical findings. Prague Med Rep 124(3):216\u2013229. https:\/\/doi.org\/10.14712\/23362936.2023.17","journal-title":"Prague Med Rep"},{"issue":"7","key":"8038_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11926-022-01077-3","volume":"24","author":"KF Boehnke","year":"2022","unstructured":"Boehnke KF, H\u00e4user W, Fitzcharles MA (2022Jul 1) Cannabidiol (CBD) in rheumatic diseases (musculoskeletal pain). Curr Rheumatol Rep 24(7):238\u2013246. https:\/\/doi.org\/10.1007\/s11926-022-01077-3","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"8038_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/MSC.1636","volume":"1","author":"N Jain","year":"2022","unstructured":"Jain N, Moorthy A (2022) Cannabinoids in rheumatology: friend, foe or a bystander? Musculoskelet Care 1(2):416. https:\/\/doi.org\/10.1002\/MSC.1636","journal-title":"Musculoskelet Care"},{"issue":"1","key":"8038_CR21","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/j.pmn.2024.08.001","volume":"26","author":"M Abbasifard","year":"2025","unstructured":"Abbasifard M, Moosavi Z, Azimi M, Kamiab Z, Bazmandegan G, Madahian A et al (2025) Effect of topical hemp (Cannabis sativa L.) seed oil on knee osteoarthritis: a randomized double-blind controlled trial. Pain Manag Nurs 26(1):e74-81. https:\/\/doi.org\/10.1016\/j.pmn.2024.08.001","journal-title":"Pain Manag Nurs"},{"key":"8038_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1657065","author":"A Mojoli","year":"2025","unstructured":"Mojoli A, Haider O, Fakih Y, Luz Gon\u00e7alves MV, Zepeda Rojas B, Xaia G et al (2025) Effects and safety of a CBD-rich Cannabis sativa oil in knee osteoarthritis: a double-blind, randomized, placebo-controlled trial \u2013 CANOA \u2013 cannabis for osteoarthritis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1657065","journal-title":"Front Pharmacol"},{"key":"8038_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100777","author":"S Pramhas","year":"2023","unstructured":"Pramhas S, Thalhammer T, Terner S, Pickelsberger D, Gleiss A, Sator S et al (2023) Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. The Lancet Regional Health - Europe. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100777","journal-title":"The Lancet Regional Health - Europe"},{"key":"8038_CR24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21564","author":"B Renslo","year":"2022","unstructured":"Renslo B, Greis A, Liu CS, Radakrishnan A, Ilyas AM (2022Jan 24) Medical cannabis use reduces opioid prescriptions in patients with osteoarthritis. Cureus. https:\/\/doi.org\/10.7759\/cureus.21564","journal-title":"Cureus"},{"issue":"1","key":"8038_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-62428-x","volume":"14","author":"Z Bawa","year":"2024","unstructured":"Bawa Z, Lewis D, Gavin PD, Libinaki R, Joubran L, El-Tamimy M et al (2024Dec 1) An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis. Sci Rep 14(1):1\u201314. https:\/\/doi.org\/10.1038\/s41598-024-62428-x","journal-title":"Sci Rep"},{"key":"8038_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.22159\/ajpcr.2023.v16i12.49934","volume":"7","author":"U Gangwal","year":"2023","unstructured":"Gangwal U, Singh J (2023) To study the efficacy of tropical application of cannabis in chronic knee joint pain patients. Asian J Pharm Clin Res 7:124\u20137. https:\/\/doi.org\/10.22159\/ajpcr.2023.v16i12.49934","journal-title":"Asian J Pharm Clin Res"},{"issue":"7","key":"8038_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jhsa.2022.03.002","volume":"47","author":"JT Heineman","year":"2022","unstructured":"Heineman JT, Forster GL, Stephens KL, Cottler PS, Timko MP, DeGeorge BR (2022Jul 1) A randomized controlled trial of topical cannabidiol for the treatment of thumb basal joint arthritis. Journal of Hand Surgery 47(7):611\u2013620. https:\/\/doi.org\/10.1016\/j.jhsa.2022.03.002","journal-title":"Journal of Hand Surgery"},{"issue":"6","key":"8038_CR28","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1097\/j.pain.0000000000002466","volume":"163","author":"J Vela","year":"2022","unstructured":"Vela J, Dreyer L, Petersen KK, Arendt-Nielsen L, Duch KS, Kristensen S (2022) Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial. Pain 163(6):1206\u20131214. https:\/\/doi.org\/10.1097\/j.pain.0000000000002466","journal-title":"Pain"},{"issue":"2","key":"8038_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/15360288.2024.2340076","volume":"38","author":"A Francis","year":"2024","unstructured":"Francis A, Erridge S, Holvey C, Coomber R, Holden W, Rucker J et al (2024) Assessment of clinical outcomes in patients with osteoarthritis: analysis from the UK medical cannabis registry. J Pain Palliat Care Pharmacother 38(2):103\u2013116. https:\/\/doi.org\/10.1080\/15360288.2024.2340076","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"8038_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/S43440-021-00270-Y","volume":"73","author":"M Bryk","year":"2021","unstructured":"Bryk M, Starowicz K (2021) Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review. Pharmacol Rep 73(3):681. https:\/\/doi.org\/10.1007\/S43440-021-00270-Y","journal-title":"Pharmacol Rep"},{"issue":"1","key":"8038_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7812\/TPP\/19.200","volume":"25","author":"S Chayasirisobhon","year":"2021","unstructured":"Chayasirisobhon S (2021) Mechanisms of action and pharmacokinetics of cannabis. Perm J 25(1):19. https:\/\/doi.org\/10.7812\/TPP\/19.200","journal-title":"Perm J"},{"issue":"4","key":"8038_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/BCPT.13710","volume":"130","author":"J Peng","year":"2022","unstructured":"Peng J, Fan M, An C, Ni F, Huang W, Luo J (2022) A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol 130(4):439\u2013456. https:\/\/doi.org\/10.1111\/BCPT.13710","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"8038_CR33","unstructured":"FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD) | FDA . [cited 2025 Nov 23]. Available from: https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd"},{"key":"8038_CR34","unstructured":"Review of cannabidiol\u202f: report of the Science Advisory Committee on Health Products Containing Cannabis. 2022;38."},{"issue":"6","key":"8038_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23063344","volume":"23","author":"C Pagano","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C (2022) Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci 23(6):3344. https:\/\/doi.org\/10.3390\/IJMS23063344","journal-title":"Int J Mol Sci"},{"issue":"5","key":"8038_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/14656566.7.5.607;WGROUP:STRING:PUBLICATION","volume":"7","author":"MP Barnes","year":"2006","unstructured":"Barnes MP (2006) Sativex\u00ae: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 7(5):607\u2013615. https:\/\/doi.org\/10.1517\/14656566.7.5.607;WGROUP:STRING:PUBLICATION","journal-title":"Expert Opin Pharmacother"},{"key":"8038_CR37","doi-asserted-by":"publisher","unstructured":"Boyaji S, Merkow J, Elman RNM, Kaye AD, Yong RJ, Urman RD (2020) The role of cannabidiol (CBD) in chronic pain management: an assessment of current evidence. Curr Pain Headache Rep. 24(2):4-. https:\/\/doi.org\/10.1007\/S11916-020-0835-4\/METRICS PubMed PMID: 31980957.","DOI":"10.1007\/S11916-020-0835-4\/METRICS"},{"key":"8038_CR38","unstructured":"Medicines Agency E. European Medicines Agency decision P\/0110\/2022 of 13 April 2022 on the acceptance of a modification of an agreed paediatric investigation plan for cannabidiol \/ delta-9-tetrahydrocannabinol (Sativex), (EMEA-000181-PIP01\u201308-M06) [Internet]. Report. Available from: www.ema.europa.eu\/contact"},{"key":"8038_CR39","unstructured":"Review of cannabidiol: Report of the Science Advisory Committee on Health Products Containing Cannabis -Canada.ca [Internet]. [cited 2026 Mar 21]. https:\/\/www.canada.ca\/en\/health-canada\/corporate\/about-health-canada\/public-engagement\/external-advisory-bodies\/health-products-containing-cannabis\/review-cannabidiol-health-products-containing-cannabis.html. Accessed 21 Mar 2026"},{"issue":"1","key":"8038_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-024-62428-X","volume":"14","author":"Z Bawa","year":"2024","unstructured":"Bawa Z, Lewis D, Gavin PD, Libinaki R, Joubran L, El-Tamimy M et al (2024) An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis. Sci Rep 14(1):11792. https:\/\/doi.org\/10.1038\/S41598-024-62428-X","journal-title":"Sci Rep"},{"issue":"3","key":"8038_CR41","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1089\/CAN.2022.0310","volume":"9","author":"O Livne","year":"2024","unstructured":"Livne O, Potter KW, Schuster RM, Gilman JM (2024) Longitudinal associations between cannabis use and cognitive impairment in a clinical sample of middle-aged adults using cannabis for medical symptoms. Cannabis & Cannabinoid Research 9(3):e933\u2013e938. https:\/\/doi.org\/10.1089\/CAN.2022.0310","journal-title":"Cannabis & Cannabinoid Research"},{"issue":"2","key":"8038_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/2049463720922884","volume":"14","author":"SPH Alexander","year":"2020","unstructured":"Alexander SPH (2020) Barriers to the wider adoption of medicinal cannabis. Br J Pain 14(2):122. https:\/\/doi.org\/10.1177\/2049463720922884","journal-title":"Br J Pain"},{"issue":"6","key":"8038_CR43","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/DAR.13476","volume":"41","author":"R Manoharan","year":"2022","unstructured":"Manoharan R, Kemper J, Young J (2022) Exploring the medical cannabis prescribing behaviours of New Zealand physicians. Drug Alcohol Rev 41(6):1355. https:\/\/doi.org\/10.1111\/DAR.13476","journal-title":"Drug Alcohol Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08038-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08038-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:49:29Z","timestamp":1775792969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["8038"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08038-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}